pharma.markets

pharma.markets

  • HOME
  • Imprint

eliapixant

Bayer will discontinue phase II development candidate eliapixant

05/02/2022 MaP 0

Review of development program led to reassessment of benefit-risk ratio in all four potential indications for the investigational P2X3 receptor antagonist Bayer today announced the […]

Translation

en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianja Japaneseko Koreanpt Portugueseru Russianes Spanish

Search

Categories

  • Age.related Degeneration
  • Alzheimer
  • Animal health
  • Asthma
  • Bioscience
  • Cancer
  • Conferences
  • COVID-19
  • EIB
  • EU
  • FCPA Investigations
  • FDA
  • Finance
  • Food
  • HHS
  • Humanitarian Aid
  • Imprint
  • Influenza
  • MS
  • News
  • Research
  • Rheumatology
  • Space Science
  • Spain
  • Sports
  • Trade Fair
  • UN
  • Vaccines
  • Valencia Comunidad
  • WHO

Reports

  • European Stroke Organisation Conference 2022: New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery
  • UNICEF and WHO warn of ‘perfect storm’ of conditions for measles outbreaks, affecting children
  • Merck Advances BioProcessing Capabilities with Acquisition of MAST® Platform from Lonza, a Leading Automated Bioreactor Sampling System
  • Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults
  • WHO issues new guidelines on abortion to help countries deliver lifesaving care

Archive

  • May 2022 (1)
  • April 2022 (2)
  • March 2022 (5)
  • February 2022 (9)
  • January 2022 (19)
  • December 2021 (37)
  • November 2021 (17)
  • October 2021 (5)
  • August 2021 (5)
  • July 2021 (5)
  • June 2021 (1)
  • May 2021 (6)
  • April 2021 (9)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
  • European Stroke Organisation Conference 2022: New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery

    04/05/2022 0
  • UNICEF and WHO warn of ‘perfect storm’ of conditions for measles outbreaks, affecting children

    27/04/2022 0
  • Merck Advances BioProcessing Capabilities with Acquisition of MAST® Platform from Lonza, a Leading Automated Bioreactor Sampling System

    05/04/2022 0
  • Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults

    15/03/2022 0
  • WHO issues new guidelines on abortion to help countries deliver lifesaving care

    09/03/2022 0
Archives
  • May 2022 (1)
  • April 2022 (2)
  • March 2022 (5)
  • February 2022 (9)
  • January 2022 (19)
  • December 2021 (37)
  • November 2021 (17)
  • October 2021 (5)
  • August 2021 (5)
  • July 2021 (5)
  • June 2021 (1)
  • May 2021 (6)
  • April 2021 (9)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
TAGS
affected africa aid bayer biontech cancer commission companies coronavirus covid-19 covid19 data economy elpais.com emergency eu europe european fda food global guarantee health hygiene links medical merck novartis pandemic pfizer production recommendations region response roche safety scheme sector spain state statistics support vaccine vaccines who

Copyright © 2022 | WordPress Theme by MH Themes

Cookie Consent with Real Cookie Banner